Sun And Taro Strike Generic Price-Fixing Settlement
US Subsidiaries Will Pay $85m To Settle With Direct Purchaser Plaintiffs
Sun Pharma’s US subsidiaries have agreed to pay out $85m to settle US antitrust litigation over generic price-fixing with direct purchaser plaintiffs.
